π§¬FREE MSRA PODCAST βAtaxia Telangiectasia: The Classic βA + T + I + Cβ Syndrome Explained!
π§ Struggling to memorise the key features of AT?This episode breaks down the essential facts for exams and practice. Perfectfor MSRA neurology revisionβlisten, learn, and recall!
Β
π§ Key Learning Points
π Definition
β’ AT = rare,inherited (autosomal recessive) disorder due to ATM gene mutation.
β’ Classic triad: Ataxia (progressive loss of coordination), Telangiectasia (dilated vessels, eyes/skin), Immunodeficiency, Cancer risk.
π Causes & Pathophysiology
β’ ATM gene defectimpairs DNA repair β genomic instability.
β’ Rapidly dividingcells (cerebellum, immune cells) most affected.
β’ Inheritance: bothparents must be carriers (autosomal recessive).
π Whoβs at risk?
β’ Children ofcarrier parents (risk β with consanguinity).
β’ Prevalence UK: 1in 100,000β300,000.
β’ Carriers: β riskof cancers (notably breast cancer in females), β life expectancy.
π Clinical Features
β’ Onset in earlychildhood (age 1β4):
ββ Progressiveataxia (worsening coordination, unsteady gait)
ββ Conjunctivaltelangiectasia (red lines in eyes, cheeks, ears)
ββ Recurrentrespiratory infections
ββ Immunodeficiency(low IgA/IgG, lymphopenia)
ββ High cancer risk(esp. lymphoma/leukaemia)
β’ Other signs:dysarthria, dysphagia, oculomotor apraxia, delayed development, growth failure,radiation sensitivity.
π Diagnosis
β’ Gold standard:Genetic testing (ATM gene mutation).
β’ Labs: βAlpha-fetoprotein (AFP), β immunoglobulins, lymphocyte subsets.
β’ MRI: Cerebellaratrophy.
β’ Immunology:Immunoglobulin levels.
β’ Memory tip: G-L-I-M (Genetics, Labs, Immunology, MRI).
π Management
β’ Supportive only(no cure):
ββ Multidisciplinaryteam: neuro, immuno, physio, oncology, etc.
ββ Physio/OT/speechtherapy
ββ Immunoglobulinreplacement
ββ Prophylacticantibiotics
ββ Cancer screening
ββ Minimiseradiation exposure (avoid X-rays/CT)
ββ Family/geneticcounselling
ββPalliative/supportive care as disease progresses
π Prognosis & Complications
β’ Progressiveneurodegeneration (wheelchair use common in teens)
β’ Median survival:20sβ30s
β’ Commoncomplications: respiratory failure, recurrent infections, cancer,swallowing/nutritional issues
β’ Carriers: β breastcancer risk in females
Β
πMore MSRA Resourcesfor Ataxia Telangiectasia:
π Revision Notes: https://www.passthemsra.com/topic/ataxia-telangiectasia-revision-notes/
π§ Flashcards: https://www.passthemsra.com/topic/ataxia-telangiectasia-flashcards/
π¬ Accordion Q&A: https://www.passthemsra.com/topic/ataxia-telangiectasia-accordion-qa-notes/
π Rapid Quiz: https://www.passthemsra.com/topic/ataxia-telangiectasia-rapid-quiz/
π Neurology Course: https://www.passthemsra.com/courses/neurology-for-the-msra/
Β
#MSRA #MSRARevision#MSRATextbook #MSRAQuiz #MSRAFlashcards #MSRAAccordions #AtaxiaTelangiectasia#Genetics #Paediatrics #Neurology #DNARepair #Immunodeficiency #CancerRisk#GPExam #MSRAOnlineRevision